Artia Global Partners LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $280 Billion distributed in 37 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Soleno Therapeutics Inc with a value of $22.2B, Merus N.V. with a value of $19.5B, Intra Cellular Therapies, Inc. with a value of $18.4B, Arcellx, Inc. with a value of $17.6B, and Novo Nordisk A S with a value of $17.2B.

Examining the 13F form we can see an decrease of $87.1B in the current position value, from $367B to 280B.

Artia Global Partners LP is based out at Miami, FL

Below you can find more details about Artia Global Partners LP portfolio as well as his latest detailed transactions.

Portfolio value $280 Billion
Healthcare: $244 Billion
ETFs: $9.01 Billion

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 37
  • Current Value $280 Billion
  • Prior Value $367 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 8 stocks
  • Additional Purchases 11 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track Artia Global Partners LP Portfolio

Follow Artia Global Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artia Global Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Artia Global Partners LP with notifications on news.